Immuneering Corp Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Immuneering Corp quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Immuneering Corp Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 29.8M shares, a 1.97% increase year-over-year.
  • Immuneering Corp annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 28.4M shares, a 7.69% increase from 2022.
  • Immuneering Corp annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 26.4M shares, a 93.8% increase from 2021.
  • Immuneering Corp annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 13.6M shares, a 175% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 29.8M +576K +1.97% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 29.7M +1.01M +3.51% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 29.4M +2.93M +11.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 28.4M +2.03M +7.69% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 29.3M +2.87M +10.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 28.6M +2.26M +8.57% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 26.4M +83.1K +0.32% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 26.4M +12.8M +93.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 26.4M +8.11M +44.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 26.4M +21.4M +433% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 26.4M +21.4M +432% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 13.6M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 18.3M +13.3M +269% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 4.95M +4.42K +0.09% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 4.95M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 4.95M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 4.95M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.